Correction to: Cell Death and Disease (2017) 8, e2682. doi:10.1038/cddis.2017.100; published online 16 March 2017
In the version of this article originally published, the following affiliation for Sang Chul Lee was incorrectly listed as 3 instead of 1.
The correct affiliations are listed below:
Byung Moo Oh1,2,5, Seon-Jin Lee1,2,5, Hee Jun Cho1, Yun Sun Park1, Jong-Tae Kim1, Suk Ran Yoon1, Sang Chul Lee1, Jong-Seok Lim3, Bo-Yeon Kim4, Yong-Kyung Choe1 and Hee Gu Lee1,2
1Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea
2Department of Biomolecular Science, University of Science and Technology (UST), Daejeon, Republic of Korea
3Department of Biological Sciences, Sookmyung Women’s University, Seoul, Republic of Korea
4World Class Institute, Korea Research Institute of Bioscience and Biotechnology, Ochang, Republic of Korea
5These authors contributed equally to this work.
The corrected article appears online together with this erratum.
The online version of the original article can be found at 10.1038/cddis.2017.100
About this article
Cancer Letters (2019)
The binding landscape of a partially-selective isopeptidase inhibitor with potent pro-death activity, based on the bis(arylidene)cyclohexanone scaffold
Cell Death & Disease (2018)